Parabolic Returns in 2022 Are Possible From 3 Growth Stocks

Three TSX growth stocks could still deliver parabolic returns in 2022, despite inflationary pressures.

| More on:

Rising interest rates affect businesses — more so for growth-oriented companies. Technology is the hardest-hit sector in an inflationary period, as tech companies rely on borrowing to pursue growth initiatives. However, there are exceptions. Some companies — not only in tech but in other sectors — are doing well amid inflationary pressures.

Sierra Wireless (TSX:SW)(NASDAQ:SWIR), Bellus Health (TSX:BLU)(NASDAQ:BLU), and Exchange Income (TSX:EIF) have survived the market selloff. All three stocks should be on the buy lists of growth investors.

Technology

Sierra Wireless ($30.15 per share) outperforms the broader market year to date at +35.2% versus -11.13%. Also, the tech stock has done well in 3.01 years, as evidenced by the 90.22% (23.83% CAGR). The $1.15 billion company provides device-to-cloud Internet of Things (IoT) solutions globally.

In Q1 2022, revenue grew 61% to US$173 million versus Q1 2021. Phil Brace, Sierra’s president and CEO, said, “We delivered strong sequential and year-over-year growth in the first quarter. We continue to work closely with our suppliers to secure components to meet the strong demand from our customers.”

The US$13.9 million net loss from operations for the quarter was a 51% improvement from US$28.5 million net loss in the same quarter last year. Sierra’s adjusted earnings from operations reached US$8.6 million compared to the US$9.6 million net loss from a year ago.

For Q2 2022, management expects revenue between US$160 million and US$175 million. Because of the continued strong demand and the investment in inventory to combat the industry-wide supply tightness, the projection is achievable.

Healthcare

As of July 1, 2022, healthcare is worst-performing sector with its nearly 50% year-to-date loss. However, Bellus Health continues to fly high. At $11.85 per share, the trailing one-year price return is 207.79%, while the year-to-date gain is 16.52%. The 12-month average price target of market analysts is $15.52 (+30.9%).

The $1.26 billion clinical-stage biopharmaceutical company develops novel therapeutics for the treatment of RCC and other cough hypersensitivity indications. Its lead product candidate and potential growth driver is BLU-5937. The Phase 2b trial was a successful and the Phase 3 program will commence in the second half of 2022.

Roberto Bellini, president and CEO of BELLUS Health, envisions BLU-5937 to be the best-in-class treatment for refractory chronic cough (RCC). He said, “The need for chronic cough treatments remains high and we are determined to fill this gap in care with a differentiated treatment option for the patients affected.”

Industrial

Exchange Income isn’t a high flyer, although market analysts covering the industrial stock recommends a buy rating and forecast a 38.8% appreciation from its current share price of $42.14 (+2.76% year to date). The overall return in 12 months should be higher if you include the hefty 5.70% dividend.

The $1.66 billion company reported record revenue ($400.22 million) in Q1 2022, which represents a 33% increase from Q1 2021. Exchange Income boasts diversified operations and is acquisition oriented. It generates steady cash flow from niche markets in the aerospace & aviation services and equipment, and manufacturing sectors.

Parabolic returns

Thus far in 2022, Sierra Wireless, Bellus Health, and Exchange Income have not disappointed investors. Barring any massive disruptions in their continuing growth efforts, the potential returns in one year could be parabolic.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

More on Investing

Person Computer 1
Investing

Trump Tariffs: You Won’t Believe What Top Stock Is Below Its 52-Week Low

The stock market has gotten off to a very different start to the year than most investors might have imagined.…

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Dividend Stocks

Where to Invest Your $7,000 TFSA Contribution for Long-Term Gains

Whether it's infrastructure, real estate or tech, these three stocks offer a promising addition to your TFSA.

Read more »

Dam of hydroelectric power plant in Canadian Rockies
Dividend Stocks

3 Low-Volatility TSX Stocks for Smoother Returns

Find stability in an era of tariff-induced uncertainty with Hydro One and two other low-volatility Canadian stocks

Read more »

coins jump into piggy bank
Dividend Stocks

Better Dividend Stock: Canadian Tire vs. CT REIT? 

Both Canadian Tire and CT REIT are good dividend stocks. However, which is a better investment depends on your financial…

Read more »

Senior uses a laptop computer
Dividend Stocks

Why Canadian Dividend Stocks Are Still a Smart Buy in 2025

Here are some tax-related reasons why investors should continue to buy Canadian dividend stocks.

Read more »

monthly desk calendar
Dividend Stocks

3 Monthly Dividend Stocks to Buy and Hold Forever

These three dividend stocks offer monthly income and so much more for investors seeking growth in their portfolio.

Read more »

up arrow on wooden blocks
Tech Stocks

3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term

If you have a long-term horizon to invest, consider investigating these three growth stocks.

Read more »

TFSA (Tax free savings account) acronym on wooden cubes on the background of stacks of coins
Dividend Stocks

3 Canadian Stocks to Consider Adding to Your TFSA in 2025

Canadian dividend stocks like Altagas are a prime candidate for your TFSA due to their attractive valuations and dividend yields.

Read more »